Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,901 to 1,920 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Characterization of mutational pattern of patients with core-binding factor acute myeloid leukemia]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2019 | 31302905 | PubTator, text mining | PubMed |
| Synthetic lethality of combined AT-101 with idarubicin in acute myeloid leukemia via blockade of DNA repair and activation of intrinsic apoptotic pathway. | Cancer Lett | 2019 | 31301319 | PubTator, text mining | PubMed |
| The response of glandular gastric transcriptome to T-2 toxin in chicks. | Food Chem Toxicol | 2019 | 31299295 | PubTator, text mining | PubMed |
| Inhibition of acetylation of histones 3 and 4 attenuates aortic valve calcification. | Exp Mol Med | 2019 | 31292436 | PubTator, text mining | PubMed |
| Influence of DNMT3A R882 mutations on AML prognosis determined by the allele ratio in Chinese patients. | J Transl Med | 2019 | 31291961 | PubTator, text mining | PubMed |
| Successful Outcome of a Case of Acute Myeloid Leukemia with t(8;21)/AML-ETO Following Langerhans Cell Histiocytosis | Turk J Haematol | 2019 | 31284703 | PubTator, text mining | PubMed |
| [Genetic abnormalities in AML]. | Rinsho Ketsueki | 2019 | 31281149 | PubTator, text mining | PubMed |
| Genome-wide DNA methylomic differences between dorsolateral prefrontal and temporal pole cortices of bipolar disorder. | J Psychiatr Res | 2019 | 31279243 | PubTator, text mining | PubMed |
| How close are we to incorporating measurable residual disease into clinical practice for acute myeloid leukemia? | Haematologica | 2019 | 31273094 | PubTator, text mining | PubMed |
| The 45th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians - Oral Session. | Bone Marrow Transplant | 2019 | 31270397 | PubTator, text mining | PubMed |
| Suicide gene‑armed measles vaccine virus for the treatment of AML. | Int J Oncol | 2019 | 31268165 | PubTator, text mining | PubMed |
| Utility of Immunophenotypic Measurable Residual Disease in Adult Acute Myeloid Leukemia-Real-World Context. | Front Oncol | 2019 | 31263671 | PubTator, text mining | PubMed |
| Rewiring of the Transcription Factor Network in Acute Myeloid Leukemia. | Cancer Inform | 2019 | 31263370 | PubTator, text mining | PubMed |
| Acquisition of Cross-Resistance to Bedaquiline and Clofazimine following Treatment for Tuberculosis in Pakistan. | Antimicrob Agents Chemother | 2019 | 31262765 | PubTator, text mining | PubMed |
| Mutant H3 histones drive human pre-leukemic hematopoietic stem cell expansion and promote leukemic aggressiveness. | Nat Commun | 2019 | 31253791 | PubTator, text mining | PubMed |
| Leveraging the Role of the Metastatic Associated Protein Anterior Gradient Homologue 2 in Unfolded Protein Degradation: A Novel Therapeutic Biomarker for Cancer. | Cancers (Basel) | 2019 | 31247903 | PubTator, text mining | PubMed |
Negative CD19 expression is associated with inferior relapse-free survival in children with RUNX1-RUNX1T1-positive acute myeloid leukaemia: results from the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 study. | Br J Haematol | 2019 | 31247675 | PubTator, text mining | PubMed |
| Development and validation of GMI signature based random survival forest prognosis model to predict clinical outcome in acute myeloid leukemia. | BMC Med Genomics | 2019 | 31242922 | PubTator, text mining | PubMed |
| SIRT3 deacetylase activity confers chemoresistance in AML via regulation of mitochondrial oxidative phosphorylation. | Br J Haematol | 2019 | 31236919 | PubTator, text mining | PubMed |
| The Role of Forkhead Box Proteins in Acute Myeloid Leukemia. | Cancers (Basel) | 2019 | 31234353 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=96